Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China
· Delayed Price · Currency is CNY 21.11
-0.20 (-0.94%)
Apr 30, 2026, 9:45 AM CST
SHE:300702 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 7,329 | 8,117 | 5,730 | 7,555 | 8,880 | 16,825 | Upgrade
|
| Market Cap Growth | 5.50% | 41.66% | -24.15% | -14.93% | -47.22% | -1.25% | Upgrade
|
| Enterprise Value | 8,536 | 9,495 | 6,950 | 8,887 | 9,411 | 16,765 | Upgrade
|
| Last Close Price | 21.31 | 23.60 | 16.63 | 21.61 | 25.40 | 48.00 | Upgrade
|
| PE Ratio | 75.87 | 58.10 | 102.44 | 276.13 | - | 82.20 | Upgrade
|
| Forward PE | 19.11 | 25.79 | 34.35 | 33.57 | 51.04 | 29.96 | Upgrade
|
| PS Ratio | 2.35 | 2.65 | 2.18 | 2.99 | 3.33 | 6.61 | Upgrade
|
| PB Ratio | 1.99 | 2.23 | 1.64 | 2.17 | 2.54 | 4.54 | Upgrade
|
| P/TBV Ratio | 2.27 | 2.55 | 1.86 | 2.43 | 2.84 | 5.05 | Upgrade
|
| P/FCF Ratio | 33.40 | 70.09 | 32.61 | - | - | - | Upgrade
|
| P/OCF Ratio | 12.45 | 17.14 | 16.63 | - | - | - | Upgrade
|
| EV/Sales Ratio | 2.74 | 3.10 | 2.64 | 3.52 | 3.53 | 6.59 | Upgrade
|
| EV/EBITDA Ratio | 13.39 | 14.54 | 16.07 | 20.21 | 57.19 | 45.18 | Upgrade
|
| EV/EBIT Ratio | 31.99 | 31.19 | 62.56 | 60.83 | - | 90.21 | Upgrade
|
| EV/FCF Ratio | 38.90 | 82.00 | 39.56 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.48 | 0.49 | 0.53 | 0.52 | 0.37 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 2.79 | 2.65 | 4.14 | 3.99 | 7.34 | 1.68 | Upgrade
|
| Debt / FCF Ratio | 8.11 | 15.29 | 10.45 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.33 | 0.35 | 0.36 | 0.39 | 0.23 | 0.02 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.94 | 1.93 | 2.88 | 3.12 | 4.92 | 0.24 | Upgrade
|
| Net Debt / FCF Ratio | 5.50 | 10.86 | 7.08 | -3.80 | -1.41 | -0.09 | Upgrade
|
| Asset Turnover | 0.48 | 0.47 | 0.41 | 0.40 | 0.44 | 0.48 | Upgrade
|
| Inventory Turnover | 1.18 | 1.07 | 0.93 | 0.86 | 1.15 | 1.26 | Upgrade
|
| Quick Ratio | 0.52 | 0.47 | 0.42 | 0.40 | 0.35 | 0.56 | Upgrade
|
| Current Ratio | 1.19 | 1.15 | 1.09 | 1.15 | 1.13 | 1.51 | Upgrade
|
| Return on Equity (ROE) | 2.63% | 3.91% | 1.60% | 0.78% | -3.30% | 5.64% | Upgrade
|
| Return on Assets (ROA) | 2.58% | 2.89% | 1.07% | 1.43% | -0.81% | 2.17% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.78% | 5.56% | 1.65% | 1.21% | -1.97% | 5.54% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.70% | 7.70% | 3.00% | 3.90% | -2.10% | 4.70% | Upgrade
|
| Earnings Yield | 1.31% | 1.72% | 0.98% | 0.36% | -1.34% | 1.22% | Upgrade
|
| FCF Yield | 2.99% | 1.43% | 3.07% | -4.78% | -6.48% | -5.93% | Upgrade
|
| Dividend Yield | 0.24% | - | 0.30% | 0.23% | - | 0.21% | Upgrade
|
| Payout Ratio | 58.45% | 41.49% | 125.49% | 186.83% | - | 54.93% | Upgrade
|
| Buyback Yield / Dilution | 2.50% | 2.53% | -2.22% | 2.18% | -0.78% | -6.61% | Upgrade
|
| Total Shareholder Return | 2.73% | 2.53% | -1.92% | 2.42% | -0.78% | -6.40% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.